Actively Recruiting
Studying MRI Features to Improve Diagnosis, Pathology Prediction, and Outcomes in Men with Prostate Lesions
Led by Zhen Li · Updated on 2025-04-27
500
Participants Needed
1
Research Sites
56 weeks
Total Duration
AI-Summary
What This Trial Is About
Prostate cancer is the second most common malignant tumor worldwide and a leading cause of cancer-related death among men. In China, it ranks sixth in male cancer incidence and causes significant mortality. The study aims to explore how magnetic resonance imaging MRI characteristics relate to diagnosis, pathology, and prognosis of prostate lesions, using pathology as the gold standard to improve clinical decision-making and prognosis evaluation. The study focuses on advanced MRI techniques including time-dependent diffusion-weighted imaging td-DWI and chemical exchange saturation transfer CEST sequences. These methods provide detailed anatomical, functional, metabolic, and physiological information about prostate lesions. The study will analyze routine and functional MRI data of patients with prostate lesions, comparing these findings with pathology results to differentiate benign from malignant lesions and predict pathological features and prognosis. Participants will undergo MRI examinations, with imaging data processed using specialized software for qualitative and quantitative analysis. Clinical information, lab tests, pathology, and treatment data will be collected to correlate with imaging findings. Researchers will measure outcomes like clinically significant prostate cancer diagnosis, Gleason grading, and biochemical recurrence over follow-up periods. The study aims to improve accuracy in diagnosis and prognosis through comprehensive imaging and clinical data evaluation.
CONDITIONS
Brief Title
Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
Research Team
Z
Zhen Li
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here